Page last updated: 2024-08-24

plerixafor and Overweight

plerixafor has been researched along with Overweight in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gardellini, A; Lanza, F; Laszlo, D; Martino, M	1
Apperley, JF; Basak, GW; Douglas, KW; Duarte, RF; Gabriel, IH; Geraldes, C; Hübel, K; Jaksic, O; Koristek, Z; Lanza, F; Lemoli, R; Mikala, G; Mohty, M; Selleslag, D; Wiktor-Jedrzejczak, W; Worel, N	1

Other Studies

2 other study(ies) available for plerixafor and Overweight

Article	Year
Plerixafor: what we still have to learn. Expert opinion on biological therapy, 2015, Volume: 15, Issue:2 Topics: Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Obesity; Overweight; Patient Selection; Transplantation, Autologous	2015
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF. Bone marrow transplantation, 2012, Volume: 47, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Benzylamines; Body Mass Index; Contraindications; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Obesity; Overweight; Retrospective Studies; Thinness; Young Adult	2012

Article

Year

Plerixafor: what we still have to learn.

Expert opinion on biological therapy, 2015, Volume: 15, Issue:2

Topics: Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Obesity; Overweight; Patient Selection; Transplantation, Autologous

2015

Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.

Bone marrow transplantation, 2012, Volume: 47, Issue:7

Topics: Adult; Aged; Aged, 80 and over; Benzylamines; Body Mass Index; Contraindications; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Obesity; Overweight; Retrospective Studies; Thinness; Young Adult

2012